Friday Lecture Series
Philip Levine Memorial Lecture
Metabolic Inputs into Cancer Epigenetics
Craig Thompson, M.D., president and chief executive officer,
Memorial Sloan-Kettering Cancer Center
February 25, 2011
3:45 p.m.-5:00 p.m. (Refreshments, 3:15 p.m., Abby Lounge)
Caspary Auditorium
Dang, L., D. W. White, S. Gross, B. D. Bennett, M. A. Bittinger, E. M. Driggers, V. R. Fantin, et al. 2009. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, (7274): 739-744
DeBerardinis, R. J., J. J. Lum, G. Hatzivassiliou, and C. B. Thompson. 2008. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metabolism 7, (1): 11-20
DeBerardinis, R. J., N. Sayed, D. Ditsworth, and C. B. Thompson. 2008. Brick by brick: Metabolism and tumor cell growth. Current Opinion in Genetics and Development 18, (1): 54-61
Jones, R. G., and C. B. Thompson. 2009. Tumor suppressors and cell metabolism: A recipe for cancer growth. Genes and Development 23, (5): 537-548
Thompson, C. B. 2009. Metabolic enzymes as oncogenes or tumor suppressors. New England Journal of Medicine 360, (8): 813-815
Ward, P. S., J. Patel, D. R. Wise, O. Abdel-Wahab, B. D. Bennett, H. A. Coller, J. R. Cross, et al. 2010. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17, (3): 225-234